Edinburgh Research Explorer

The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2

Research output: Contribution to journalArticle

  • T C Booth
  • M Nathan
  • A D Waldman
  • A-M Quigley
  • A H Schapira
  • J Buscombe
Original languageEnglish
Pages (from-to)236-44
Number of pages9
JournalAmerican Journal of Neuroradiology
Volume36
Issue number2
DOIs
Publication statusPublished - Feb 2015
Externally publishedYes

Abstract

SUMMARY: The functional imaging technique most widely used in European clinics to differentiate a true parkinsonian syndrome from vascular parkinsonism, drug-induced changes, or essential tremor is dopamine-transporter SPECT. This technique commonly reports dopamine-transporter function, with decreasing striatal uptake demonstrating increasingly severe disease. The strength of dopamine-transporter SPECT is that nigrostriatal degeneration is observed in both clinically inconclusive parkinsonism and early, even premotor, disease. In this clinical review (Part 2), we present the dopamine-transporter SPECT findings in a variety of neurodegenerative diseases, including multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, and dementia with Lewy bodies. The findings in vascular parkinsonism, drug-induced parkinsonism, and essential tremor are also described. It is hoped that this technique will be the forerunner of a range of routinely used, process-specific ligands that can identify early degenerative disease and subsequently guide disease-modifying interventions.

    Research areas

  • Corpus Striatum, Dopamine Plasma Membrane Transport Proteins, Essential Tremor, Humans, Lewy Body Disease, Multiple System Atrophy, Parkinsonian Disorders, Supranuclear Palsy, Progressive, Tomography, Emission-Computed, Single-Photon, Journal Article, Research Support, Non-U.S. Gov't, Review

ID: 45403688